Answers are grounded in this paper and cite their sources.
Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material composed principally of surfactant phospholipid and apoproteins within the alveoli, resulting in impairment of gas exchange It was first described by Rosen et al. in 1958 [1]. There is a wide range of clinical manifestation of PAP ranging from respiratory failure to spontaneous resolution.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: